These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36711047)

  • 1. Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis.
    Ullah SE; Zahoor MM; Gupta S; Boparai S; Muneeb M; Eltieb SAH; Shankar A; Kidiavai HM; Vohra RR; Devi A; Bhura ZA; Aslam ZM; Shoaib M
    Can J Respir Ther; 2023; 59():1-7. PubMed ID: 36711047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis.
    Arshid S; Ullah SE; Imran J; Syed MA; Choradia A; Gousy N; Boparai S; Shoaib M; Shah BB; Netha A
    Can J Respir Ther; 2023; 59():214-222. PubMed ID: 37927455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
    JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001506. PubMed ID: 19370568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of hypertonic saline with or without hyaluronic acid among patients with cystic fibrosis: a systematic review and meta-analysis.
    Khan Z; Naeem MO; Amin DA; Amin L; Shah A; Khaliq SU; Azhar A; Naz S; Shujauddin SM; Arshad MA; Ali SJ; Sajid EU; Jawad S
    Ann Med Surg (Lond); 2024 Oct; 86(10):6091-6096. PubMed ID: 39359762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.
    Stahl M; Wielpütz MO; Ricklefs I; Dopfer C; Barth S; Schlegtendal A; Graeber SY; Sommerburg O; Diekmann G; Hüsing J; Koerner-Rettberg C; Nährlich L; Dittrich AM; Kopp MV; Mall MA
    Am J Respir Crit Care Med; 2019 May; 199(10):1238-1248. PubMed ID: 30409023
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis.
    Amin R; Stanojevic S; Kane M; Webster H; Ratjen F
    Respir Med; 2016 Mar; 112():59-64. PubMed ID: 26856191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R; Subbarao P; Jabar A; Balkovec S; Jensen R; Kerrigan S; Gustafsson P; Ratjen F
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.
    Subbarao P; Stanojevic S; Brown M; Jensen R; Rosenfeld M; Davis S; Brumback L; Gustafsson P; Ratjen F
    Am J Respir Crit Care Med; 2013 Aug; 188(4):456-60. PubMed ID: 23742699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.
    Tiddens HAWM; Chen Y; Andrinopoulou ER; Davis SD; Rosenfeld M; Ratjen F; Kronmal RA; Hinckley Stukovsky KD; Dasiewicz A; Stick SM;
    Lancet Respir Med; 2022 Jul; 10(7):669-678. PubMed ID: 35286860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of nebulized hypertonic saline for muco-obstructive lung diseases: a systematic review and meta-analysis with trial sequential analysis.
    Zhang Y; Song A; Liu J; Dai J; Lin J
    J Investig Med; 2021 Mar; 69(3):742-748. PubMed ID: 33272932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomes.
    Donaldson SH; Danielle Samulski T; LaFave C; Zeman K; Wu J; Trimble A; Ceppe A; Bennett WD; Davis SD
    J Cyst Fibros; 2020 Nov; 19(6):942-948. PubMed ID: 32669217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M;
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis.
    Vermeulen F; Proesmans M; Boon M; Havermans T; De Boeck K
    Thorax; 2014 Jan; 69(1):39-45. PubMed ID: 24021874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.
    Anuradha KWDA; Gunathilaka PKG; Wickramasinghe VP
    Pediatr Pulmonol; 2021 Feb; 56(2):509-515. PubMed ID: 33295693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.